Tom G. Obrig

4.6k total citations · 1 hit paper
63 papers, 3.7k citations indexed

About

Tom G. Obrig is a scholar working on Endocrinology, Immunology and Infectious Diseases. According to data from OpenAlex, Tom G. Obrig has authored 63 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Endocrinology, 31 papers in Immunology and 23 papers in Infectious Diseases. Recurrent topics in Tom G. Obrig's work include Escherichia coli research studies (34 papers), Viral gastroenteritis research and epidemiology (21 papers) and Immune Cell Function and Interaction (19 papers). Tom G. Obrig is often cited by papers focused on Escherichia coli research studies (34 papers), Viral gastroenteritis research and epidemiology (21 papers) and Immune Cell Function and Interaction (19 papers). Tom G. Obrig collaborates with scholars based in United States, Japan and Canada. Tom G. Obrig's co-authors include C B Louise, Britta Denise Hardesty, William Culp, Wallace L. McKeehan, Timothy P. Moran, Tiffany R. Keepers, Clifford A. Lingwood, Beth Boyd, J E Brown and James D. Irvin and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Molecular Biology.

In The Last Decade

Tom G. Obrig

63 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Mechanism by which Cycloheximide and Related Glutarimide Antibiotics Inhibit Peptide Synthesis on Reticulocyte Ribosomes

1971 433 citations Tom G. Obrig et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tom G. Obrig United States	33	1.8k	1.5k	1.3k	1.0k	419	63	3.7k
Masatoshi Noda Japan	33	893 0.5×	802 0.5×	896 0.7×	1.1k 1.1×	217 0.5×	119	3.5k
Jay C. Vary United States	28	707 0.4×	1.0k 0.7×	468 0.4×	1.5k 1.4×	283 0.7×	70	3.6k
Ivar Lönnroth Sweden	27	760 0.4×	459 0.3×	610 0.5×	1.1k 1.1×	108 0.3×	89	2.7k
Jessica Jones‐Carson United States	29	898 0.5×	837 0.6×	978 0.7×	884 0.9×	167 0.4×	46	3.7k
Athanasia Koutsouris United States	28	1.2k 0.7×	870 0.6×	394 0.3×	1.4k 1.3×	71 0.2×	41	3.1k
Eva González‐Roca Spain	30	998 0.6×	749 0.5×	279 0.2×	1.9k 1.8×	159 0.4×	78	3.6k
A. M. Pappenheimer United States	38	578 0.3×	587 0.4×	2.7k 2.1×	1.7k 1.7×	1.4k 3.3×	93	4.7k
Michael U. Shiloh United States	25	360 0.2×	1.6k 1.1×	1.4k 1.1×	1.7k 1.7×	107 0.3×	37	4.6k
Michael Wacker United States	30	601 0.3×	411 0.3×	232 0.2×	2.2k 2.2×	237 0.6×	80	3.8k
Cristina Ibarra Argentina	23	645 0.4×	509 0.3×	227 0.2×	764 0.7×	87 0.2×	103	1.9k

Countries citing papers authored by Tom G. Obrig

Since Specialization

Citations

This map shows the geographic impact of Tom G. Obrig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom G. Obrig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom G. Obrig more than expected).

Fields of papers citing papers by Tom G. Obrig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom G. Obrig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom G. Obrig. The network helps show where Tom G. Obrig may publish in the future.

Co-authorship network of co-authors of Tom G. Obrig

This figure shows the co-authorship network connecting the top 25 collaborators of Tom G. Obrig. A scholar is included among the top collaborators of Tom G. Obrig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom G. Obrig. Tom G. Obrig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Obata, Fumiko, Koujiro Tohyama, Adrian D. Bonev, et al.. (2008). Shiga Toxin 2 Affects the Central Nervous System through Receptor Globotriaosylceramide Localized to Neurons. The Journal of Infectious Diseases. 198(9). 1398–1406. 78 indexed citations

Jandhyala, Dakshina M., Amrita Ahluwalia, Tom G. Obrig, & Cheleste M. Thorpe. (2008). ZAK: a MAP3Kinase that transduces Shiga toxin- and ricin-induced proinflammatory cytokine expression. Cellular Microbiology. 10(7). 1468–1477. 88 indexed citations

Guessous, Fadila, et al.. (2005). Shiga toxin 2 and lipopolysaccharide cause monocytic THP-1 cells to release factors which activate platelet function. Thrombosis and Haemostasis. 94(11). 1019–1027. 20 indexed citations

Carneiro, Benedito A., Jun Fujii, Gerly Anne de Castro Brito, et al.. (2005). Caspase and Bid Involvement inClostridium difficileToxin A-Induced Apoptosis and Modulation of Toxin A Effects by Glutamine and Alanyl-Glutamine In Vivo and In Vitro. Infection and Immunity. 74(1). 81–87. 64 indexed citations

Ghosh, Swagata, et al.. (2004). Shiga toxin binds to activated platelets. Journal of Thrombosis and Haemostasis. 2(3). 499–506. 46 indexed citations

Houpt, Eric R., Tom G. Obrig, Christopher A. Moskaluk, et al.. (2002). The Mouse Model of Amebic Colitis Reveals Mouse Strain Susceptibility to Infection and Exacerbation of Disease by CD4+ T Cells. The Journal of Immunology. 169(8). 4496–4503. 108 indexed citations

Andreoli, Sharon, Howard Trachtman, David W. K. Acheson, Richard L. Siegler, & Tom G. Obrig. (2002). Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatric Nephrology. 17(4). 293–298. 68 indexed citations

Brito, Gerly Anne de Castro, et al.. (2002). Mechanism ofClostridium difficileToxin A–Induced Apoptosis in T84 Cells. The Journal of Infectious Diseases. 186(10). 1438–1447. 107 indexed citations

Rapoport, Aaron P., Timothy F. Chen, Karen Rosell, et al.. (2001). Flavopiridol Induces Apoptosis and Caspase-3 Activation of a Newly Characterized Burkitt's Lymphoma Cell Line Containing Mutant P53 Genes. Blood Cells Molecules and Diseases. 27(3). 610–624. 16 indexed citations

10.

Fujii, Jun, Yoshimasa Kinoshita, Takashi Yutsudo, et al.. (2001). Toxicity of Shiga Toxin 1 in the Central Nervous System of Rabbits. Infection and Immunity. 69(10). 6545–6548. 17 indexed citations

11.

Obrig, Tom G.. (1997). Shiga toxin mode of action in E COLI O157 H7 disease. Frontiers in bioscience. 2(4). d635–642. 20 indexed citations

12.

Louise, C B & Tom G. Obrig. (1995). Specific Interaction of Escherichia coli 0157:H7-Derived Shiga-like Toxin II with Human Renal Endothelial Cells. The Journal of Infectious Diseases. 172(5). 1397–1401. 158 indexed citations

13.

Louise, C B, Timothy P. Moran, Clifford A. Lingwood, et al.. (1995). Binding of [¹²⁵I]Shiga-like Toxin-1 to Human Endothelial Cells: Implications for the Pathogenesis of Shiga Toxin-associated Hemolytic Uremic Syndrome. Endothelium. 3(2). 159–170. 4 indexed citations

14.

Pickering, Larry K., et al.. (1994). Hemolytic-uremic syndrome and enterohemorrhagic Escherichia coli. PubMed. 13(6). 459–475. 80 indexed citations

15.

Louise, C B & Tom G. Obrig. (1994). Human Renal Microvascular Endothelial Cells as a Potential Target in the Development of the Hemolytic Uremic Syndrome as Related to Fibrinolysis Factor Expression, in Vitro. Microvascular Research. 47(3). 377–387. 31 indexed citations

16.

Obrig, Tom G.. (1994). [52] Toxins that inhibit host protein synthesis. Methods in enzymology on CD-ROM/Methods in enzymology. 235. 647–656. 10 indexed citations

17.

Obrig, Tom G., et al.. (1993). Direct Cytotoxic Effects of Hemorrhagic Toxins from Crotalus ruber ruber and Crotalus atrox on Human Vascular Endothelial Cells, in Vitro. Microvascular Research. 46(3). 412–416. 13 indexed citations

18.

Verschoor, Adriana, et al.. (1989). Three-dimensional reconstruction of mammalian 40 S ribosomal subunit. Journal of Molecular Biology. 209(1). 115–126. 23 indexed citations

19.

Brown, J E, Tom G. Obrig, Michael A. Ussery, & Timothy P. Moran. (1986). Shiga toxin from Shigella dysenteriae 1 inhibits protein synthesis in reticulocyte lysates by inactivation of aminoacyl-tRNA binding. Microbial Pathogenesis. 1(4). 325–334. 23 indexed citations

20.

Obrig, Tom G. & David Gottlieb. (1970). In Vitro Protein Synthesis and Aging in Rhizoctonia solani. Journal of Bacteriology. 101(3). 755–762. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact